17 Einträge gefunden

1. The influence of olanzapine versus risperidone on facial expression of emotions in schizophrenia--preliminary results of a facial electromyogram study.

   1. Wolf, Karsten
   2. Mass, Reinhard
   3. Kiefer, Falk
   4. Eckert, Kirsten
   5. Stritzky, Alexandra V
   6. Haasen, Christian
   7. Wiedemann, Klaus

   2005 - Forschungsinformationssystem des UKE
2. Neuroleptic dysphoria 50 years later.

   1. Awad, A George
   2. Naber, Dieter

   2005 - Forschungsinformationssystem des UKE
3. Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.

   1. Lambert, Martin
   2. Haro, J M
   3. Novick, D
   4. Edgell, E T
   5. Kennedy, L
   6. Ratcliffe, M
   7. Naber, Dieter

   2005 - Forschungsinformationssystem des UKE
4. Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study.

   1. Lambert, Martin
   2. Conus, P
   3. Schimmelmann, B G
   4. Eide, P
   5. Ward, J
   6. Yuen, H
   7. Schacht, M

   2005 - Forschungsinformationssystem des UKE
5. A simple switching strategy for inadequately treated patients with schizophrenia to olanzapine: changes in psychopathology and subjective well-being.

   1. Kluge, M
   2. Wehmeier, P M
   3. Dittmann, R W
   4. Langer, F
   5. Czekalla, J
   6. Lehmann, M
   7. Kessler, F H

   2005 - Forschungsinformationssystem des UKE
6. Hand-offs and trade-offs in psychiatric care.

   1. Naber, Dieter
   2. Pincus, Harold

   2005 - Forschungsinformationssystem des UKE
7. [Comments on a critical consideration of a modern construct--subjective life quality]

   1. Meyer, T
   2. Karow, Anne
   3. Naber, Dieter
   4. Franz, M

   2005 - Forschungsinformationssystem des UKE
8. [Identification of possible cognizance parameters of "mimic disintegration" in schizophrenia using facial electromyography]

   1. Wolf, K
   2. Köppel, S
   3. Mass, R
   4. Naber, Dieter

   2005 - Forschungsinformationssystem des UKE
9. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis.

   1. Lambert, Martin
   2. Conus, P
   3. Lubman, D I
   4. Wade, D
   5. Yuen, H
   6. Moritz, Steffen
   7. Naber, Dieter

   2005 - Forschungsinformationssystem des UKE
10. Subjective effects of antipsychotic treatment.

    1. Naber, Dieter

    2005 - Forschungsinformationssystem des UKE
11. Subjective well-being under the neuroleptic treatment and its relevance for compliance.

    1. Naber, Dieter
    2. Karow, Anne
    3. Lambert, Martin

    2005 - Forschungsinformationssystem des UKE
12. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia.

    1. Naber, Dieter
    2. Riedel, M
    3. Klimke, A
    4. Vorbach, E-U
    5. Lambert, Martin
    6. Kühn, K-U
    7. Bender, S

    2005 - Forschungsinformationssystem des UKE
13. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.

    1. Kämpf, Philipp
    2. Agelink, M W
    3. Naber, Dieter

    2005 - Forschungsinformationssystem des UKE
14. The facial pattern of disgust, appetence, excited joy and relaxed joy: an improved facial EMG study.

    1. Wolf, Karsten
    2. Mass, Reinhard
    3. Ingenbleek, Thomas
    4. Kiefer, Falk
    5. Naber, Dieter
    6. Wiedemann, Klaus

    2005 - Forschungsinformationssystem des UKE
15. [Pro and contra: basic precedence of atypical neuroleptics]

    1. Naber, Dieter
    2. Dose, Matthias

    2005 - Forschungsinformationssystem des UKE
16. Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.

    1. Breier, Alan
    2. Berg, Paul H
    3. Thakore, Jogin H
    4. Naber, Dieter
    5. Gattaz, Wagner F
    6. Cavazzoni, Patrizia
    7. Walker, Daniel J

    2005 - Forschungsinformationssystem des UKE
17. [Treatment oriented to subjective well- being rather than symptom amelioration "at all costs"--paradigm change in treatment with antipsychotics]

    1. Karow, Anne
    2. Naber, Dieter

    2005 - Forschungsinformationssystem des UKE